RadNet Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio November 27, 2023 by Quantib LOS ANGELES, Nov. 27, 2023 -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging ... Read Post
Arthur Post Uiterweer, CEO of Quantib, to pursue a new adventure as of October 1st October 02, 2023 by Quantib Rotterdam, The Netherlands, October 2nd, 2023 – Today marks an important day for our team as we say goodbye to Arthur Post Uiterweer, Quantib’s CEO, ... Read Post
Experts highlight the importance of introducing advanced neuroradiology tools for the diagnosis of Alzheimer's disease September 21, 2023 by Quantib Rotterdam, The Netherlands; Rome, Italy, September 21st, 2023 – Today, Rome marked World Alzheimer's Day with an event focused on cognitive decline, ... Read Post
RadNet’s Quantib B.V. Subsidiary Receives FDA Clearance for its Quantib Prostate™ 3.0 Software May 01, 2023 by Quantib Rotterdam, The Netherlands; Los Angeles, Calif., April 28, 2023 – RadNet, Inc., (NASDAQ: RDNT) today announced that it has received FDA clearance for ... Read Post
Quantib to be a partner of the European COMFORT project April 05, 2023 by Quantib The COMFORT project is a new interdisciplinary research endeavour set out to improve the health and well-being of people affected by prostate and ... Read Post
Wiro Niessen becomes the new Dean of the Faculty of Medical Sciences of the University of Groningen February 01, 2023 by Quantib Per 1st of February 2023, Wiro Niessen, Founder and Scientific lead of Quantib, has become the new Dean of the Faculty of Medical Sciences of the ... Read Post
Quantib partners up with Bayer to accelerate patient access to AI in radiology November 24, 2022 by Quantib Quantib® Prostate, our AI software for prostate MRI reading, will also be available within Bayer’s CalanticTM Digital Solutions platform. This ... Read Post
RadNet AI Subsidiaries, DeepHealth and Quantib, Obtain FDA Clearance for Mammography and Prostate AI Tools May 16, 2022 by Quantib Cambridge, Mass.; Rotterdam, The Netherlands; Los Angeles, Calif., May 13, 2022 – RadNet, Inc., (NASDAQ: RDNT) today announced that it has received ... Read Post
Radnet to acquire Quantib January 24, 2022 by Quantib RadNet to acquire Quantib and Aidence, taking giant leap in the expansion of its AI technology The two acquisitions provide RadNet with the basis for ... Read Post
Quantib launches ND 2.0 January 18, 2022 by Quantib Rotterdam, The Netherlands – Quantib, a market leader in artificial intelligence solutions for radiology, released a significant upgrade of their ... Read Post
Quantib launches Node 2.4.0 November 17, 2021 by Quantib Rotterdam, The Netherlands – Quantib, a market leader in artificial intelligence solutions for precision diagnosis, announced the significant upgrade ... Read Post
Quantib launches Quantib® Prostate 1.3 October 12, 2021 by Quantib Rotterdam, The Netherlands – October 12, 2021 – Quantib, a market leader in artificial intelligence solutions for precision diagnosis, announced ... Read Post
Quantib names Quirine van Voorst COO September 03, 2021 by Quantib Quirine van Voorst has been named Chief Operating Officer of Quantib effective September 1, 2021. Rudolf Scholte, founder and former COO of Quantib, ... Read Post
Quantib to name Arthur Post Uiterweer CEO January 23, 2018 by Quantib Arthur Post Uiterweer, current Chief Commercial Officer of Quantib, has been named CEO of Quantib effective February 1, 2018. Rudolf Scholte, Founder ... Read Post
Previous Next

    SUBSCRIBE FOR UPDATES

    Posts by Topic

    Recent Posts

    ©2025 DeepHealth